Table 3.
Laboratory values by gender and phenotype in CFLD patients
Description | All n =561 | Males n =353 | Females n =208 | p value | No known varices n =154 | Varices present n =384 | p value | No liver transplant n =470 | Liver transplant n =91 | p value |
---|---|---|---|---|---|---|---|---|---|---|
Male gender, n (%) | 353 (63) | 0.0006 | 98 (64) | 241 (63) | 0.94 | 294 (63) | 59 (65) | 0.85 | ||
Alanine aminotransferase (ALT), IU/L | n =532 | n =334 | n =198 | n =150 | n =365 | n =454 | n=78 | |||
Median (25th, 75th) | 41 (28, 67) | 44 (28, 71) | 38 (26, 36) | 0.01a | 46 (31, 68) | 40 (27, 66) | 0.09 | 42 (28, 68) | 39 (27, 59) | 0.56 |
Gamma-glutamyl transferase (GGT), IU/L | n =456 | n =295 | n =161 | n =128 | n =316 | n =390 | n =66 | |||
Median (25th, 75th) | 60 (30, 123) | 66 (33, 127) | 51 (25, 113) | 0.04 | 63 (30, 106) | 57 (30, 126) | 0.96 | 61 (31, 123) | 52 (25, 134) | 0.83 |
Total bilirubin, mg/dL | n =474 | n =292 | n =182 | n =119 | n =341 | n =394 | n =80 | |||
Median (25th, 75th) | 0.8 (0.5, 1.3) | 0.8 (0.5, 1.3) | 0.8 (0.5, 1.4) | 0.74 | 0.7 (0.4, 1.0) | 0.9 (0.5, 1.5) | 0.0001 | 0.8 (0.5, 1.2) | 1.0 (0.7, 1.6) | 0.001 |
Direct bilirubin, mg/dL | n =231 | n =143 | n =88 | n =53 | n =1 70 | n =194 | n =37 | |||
Median (25th, 75th) | 0.3 (0.2, 0.6) | 0.3 (0.2, 0.6) | 0.3 (0.2, 0.6) | 0.66 | 0.2 (0.1, 0.4) | 0.4 (0.2, 0.7) | 0.0001 | 0.3 (0.2, 0.5) | 0.4 (0.3, 0.8) | 0.01 |
Albumin, g/dL | n =493 | n =306 | n =187 | n =138 | n =342 | n =418 | n =75 | |||
Median (25th, 75th) | 3.6 (3.2, 4.0) | 3.7 (3.3, 4.0) | 3.5 (3.0, 3.9) | 0.0007 | 3.8 (3.3, 4.1) | 3.5 (3.1, 3.9) | 0.001 | 3.7 (3.2, 4.0) | 3.3 (2.9, 3.8) | 0.0002 |
International normalized ratio (INR) | n =360 | n =223 | n =137 | n =100 | n =249 | n =310 | n =50 | |||
Median (25th, 75th) | 1.2 (1.1, 1.4) | 1.3 (1.1, 1.4) | 1.2 (1.1, 1.3) | 0.03 | 1.2 (1.1, 1.3) | 1.3 (1.1, 1.4) | <0.0001 | 1.2 (1.1, 1.4) | 1.4 (1.2, 1.7) | <0.0001 |
Platelet count (×109/L) | n =464 | n =290 | n =174 | n =134 | n =313 | n =402 | n =62 | |||
Median (25th, 75th) | 103 (65, 166) | 101 (62, 160) | 111 (69, 172) | 0.34 | 145 (87, 198) | 88 (56, 142) | <0.0001 | 113 (70, 171) | 78 (54, 99) | <0.0001 |
< 150, n (%) | 324 (70) | 208 (72) | 116 (67) | 0.65 | 74 (55) | 243 (78) | 0.048 | 269 (67) | 55 (89) | 0.19 |
< 75, n (%) | 140 (30) | 91 (31) | 49 (28) | 0.62 | 21 (16) | 117 (37) | 0.0006 | 113 (28) | 27 (44) | 0.10 |
p values (<0.05 shown in bold) generated using Fisher's exact test (for categorical data) or Wilcoxon rank sum (for medians).
Data presented as median with 25th and 75th percentiles or frequency with percent.
Apparent difference between genders is clinically non-significant due to different ULN in ALT for males and females.